FDA Advisers Weigh Pfizer’s COVID-19 Vaccine

A panel of advisers to the Food and Drug Administration meets Thursday to evaluate Pfizer

Experts will assess the benefits and risks of authorizing what could be the first COVID-19 vaccine for emergency use in the U.S.

(Image credit: Jacquelyn Martin/AP)

Read the full post on Health Care : NPR